Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 126-131 , January 2010

Hemoglobin A1c in predicting progression to diabetes

  • Tomoko Nakagami

      Affiliations

    • Diabetes Centre, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku Tokyo 162-8666, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 3 3353 8111; fax: +81 3 3358 1941.
    • ,
  • Naoko Tajima

      Affiliations

    • Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
    • ,
  • Toshihide Oizumi

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
    • ,
  • Shigeru Karasawa

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
    • ,
  • Kiriko Wada

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
    • ,
  • Wataru Kameda

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
    • ,
  • Shinji Susa

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
    • ,
  • Takeo Kato

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
    • ,
  • Makoto Daimon

      Affiliations

    • Third Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan

Received 18 June 2009 ,Revised 27 October 2009 ,Accepted 2 November 2009.

References 

  1. International Diabetes Federation, Diabetes Atlas, 2nd ed., The Federation, Brussels, 2003.
  2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J. Med. 2002;346:393–403
  3. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J. Med. 2001;344:1343–1350
  4. Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, Kaku K On behalf of Voglibose Ph-3 Study Group. Voglibose for prevention of type2 diabetes mellitus: a randomized, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet. 2009;373:1607–1614
  5. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Eng J Med. 2008;359:1577–1589
  6. Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl. J. Med. 2008;358:2545–2559
  7. http://www.mhlw.go.jp/houdou/2008/04/h0430-2.html. (In Japanese).
  8. Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S, et al. The Japanese national health screening and intervention aimed at preventing worsening of the metabolic syndrome. Int. Heart J. 2008;49:193–203
  9. Nijpels G, Popp-Snijders C, Kostense PJ, Bouter LM, Heine RJ. Fasting proinsulin and 2h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance; the Hoorn study. Diabetologia. 1996;39:113–118
  10. Qiao Q, Lindstrom J, Valle TT, Tuomilehto J. Progression to clinically diagnosed and treated diabetes from impaired glucose tolerance and impaired fasting glycaemia. Diabet. Med. 2003;20:1027–1033
  11. Droumaguet C, Balkau B, Simon D, Caces E, Tichet J, Charles MA, et al. Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care. 2006;29:1619–1625
  12. Inoue K, Matsumoto M, Kobayashi Y. The combination of fasting plasma glucose and glycosylated hemoglobin predicts type 2 diabetes in Japanese workers. Diabetes Res. Clin. Pract. 2007;77:451–458
  13. American Diabetes Association. Standards of medical care in diabetes 2006. Diabetes Care 20 (2006) s4–s42.
  14. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation, Part1: Diagnosis and Classification of Diabetes Mellitus. WHO, Geneva, 1999.
  15. Daimon M, Oizumi T, Saitoh T, Kameda W, Hirata A, Yamaguchi H, et al. Funagata Study. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care. 2003;27:15–20
  16. Shima K, Endo J, Oimomi M, Oshima I, Omori Y, Katayama Y. Interlaboratory difference in GHb measurement in Japan - the fourth report of the GHb Standardization Committee, the Japan Diabetes Society. J. Jpn. Diabetes Soc. 1997;40:321–326(In Japanese)
  17. Tominaga M, Makino H, Yoshino G, Kuwa K, Takei I, Aono Y, et al. Japanese standard reference material JDS Lot 2 for haemoglobin A1c. II: present state of standardization of haemoglobin A1c in Japan using the new reference material in routine clinical assays. Ann. Clin. Biochem. 2005;42:47–50
  18. Tominaga M, Makino H, Yoshino G, Kuwa K, Takei I, Aono Y, et al. Japanese standard reference material for JDS Lot 2 haemoglobin A1c. I: comparison of Japan diabetes Society-assigned values to those obtained by the Japanese and USA domestic standardization programmes and by the International Federation of Clinical Chemistry reference laboratories. Ann. Clin. Biochem. 2005;42:41–46
  19. Zweig MH, Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993;39:561–577
  20. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ For the A1c-Derived Average Glucose (ADAG) Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473–1478
  21. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch. Intern. Med. 2007;167:1545–1551
  22. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA (1c). Diabetes Care. 2003;26:881–885
  23. Treatment Guide for Diabetes 2007. Japan Diabetes Society, Bunkodo, 2007.
  24. The International Expert Committee. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 32 (2009) 1–8.
  25. http://www.arkray.co.jp/nm/press/20070404.html.(In Japanese).
  26. Nakagami T, Tajima N, Oizumi T, Karasawa S, Wada K, Kameda W, et al. Raised fasting plasma glucose a better predictor of diabetes than the IDF definition of the metabolic syndrome. Diabetes Res. Clin. Pract. 2009;85:19–21
  27. Forouhi NG, Luan J, Hennings S, Wareham NJ. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990–2000. Diabet Med. 2007;24:200–207

☆ Research grant: Japanese Ministry of Health, Labour and Warfare, Some results of this paper were presented at the 43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam, The Netherlands in September 2007.

PII: S0168-8227(09)00472-0

doi: 10.1016/j.diabres.2009.11.001

Diabetes Research and Clinical Practice
Volume 87, Issue 1 , Pages 126-131 , January 2010

Article Tools

* Image Usage & Resolution